drugset / Trial / NCT00333372

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia

NCT00333372

Phase 2 Completed 440 enrolled Zeria Pharmaceutical
RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate the efficacy of Z-338 in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms in order to further determine the optimal dosage and efficacy parameters for PhaseIII clinical trials.

Timeline

Start
2006-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Acotiamide Small molecule

Indications